vs

Side-by-side financial comparison of Dexcom (DXCM) and SBA Communications (SBAC). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $703.4M, roughly 1.8× SBA Communications). SBA Communications runs the higher net margin — 26.3% vs 21.2%, a 5.1% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -1.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 3.2%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

SBA Communications Corporation is a real estate investment trust which owns and operates wireless infrastructure in the United States, Canada, Central America, South America, and South Africa. It was founded in 1989 as Steven Bernstein and Associates by Steven Bernstein.

DXCM vs SBAC — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.8× larger
DXCM
$1.3B
$703.4M
SBAC
Growing faster (revenue YoY)
DXCM
DXCM
+23.1% gap
DXCM
21.6%
-1.6%
SBAC
Higher net margin
SBAC
SBAC
5.1% more per $
SBAC
26.3%
21.2%
DXCM
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
3.2%
SBAC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
SBAC
SBAC
Revenue
$1.3B
$703.4M
Net Profit
$267.3M
$184.9M
Gross Margin
62.9%
Operating Margin
25.6%
48.7%
Net Margin
21.2%
26.3%
Revenue YoY
21.6%
-1.6%
Net Profit YoY
153.6%
-15.1%
EPS (diluted)
$0.67
$1.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
SBAC
SBAC
Q1 26
$1.3B
$703.4M
Q4 25
$1.3B
$719.6M
Q3 25
$1.2B
$732.3M
Q2 25
$1.2B
$699.0M
Q1 25
$1.0B
$664.2M
Q4 24
$1.1B
$693.7M
Q3 24
$994.2M
$667.6M
Q2 24
$1.0B
$660.5M
Net Profit
DXCM
DXCM
SBAC
SBAC
Q1 26
$267.3M
$184.9M
Q4 25
$267.3M
$370.4M
Q3 25
$283.8M
$236.8M
Q2 25
$179.8M
$225.8M
Q1 25
$105.4M
$220.7M
Q4 24
$151.7M
$178.8M
Q3 24
$134.6M
$258.5M
Q2 24
$143.5M
$162.8M
Gross Margin
DXCM
DXCM
SBAC
SBAC
Q1 26
62.9%
Q4 25
62.9%
75.6%
Q3 25
60.5%
74.1%
Q2 25
59.5%
75.4%
Q1 25
56.9%
76.9%
Q4 24
58.9%
78.1%
Q3 24
59.7%
77.5%
Q2 24
62.4%
78.6%
Operating Margin
DXCM
DXCM
SBAC
SBAC
Q1 26
25.6%
48.7%
Q4 25
25.6%
41.5%
Q3 25
20.1%
51.1%
Q2 25
18.4%
47.9%
Q1 25
12.9%
50.4%
Q4 24
17.0%
55.1%
Q3 24
15.3%
56.3%
Q2 24
15.7%
53.7%
Net Margin
DXCM
DXCM
SBAC
SBAC
Q1 26
21.2%
26.3%
Q4 25
21.2%
51.5%
Q3 25
23.5%
32.3%
Q2 25
15.5%
32.3%
Q1 25
10.2%
33.2%
Q4 24
13.6%
25.8%
Q3 24
13.5%
38.7%
Q2 24
14.3%
24.7%
EPS (diluted)
DXCM
DXCM
SBAC
SBAC
Q1 26
$0.67
$1.74
Q4 25
$0.67
$3.47
Q3 25
$0.70
$2.20
Q2 25
$0.45
$2.09
Q1 25
$0.27
$2.04
Q4 24
$0.37
$1.61
Q3 24
$0.34
$2.40
Q2 24
$0.35
$1.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
SBAC
SBAC
Cash + ST InvestmentsLiquidity on hand
$917.7M
$269.1M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$2.7B
Total Assets
$6.3B
$11.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
SBAC
SBAC
Q1 26
$917.7M
$269.1M
Q4 25
$917.7M
$271.2M
Q3 25
$1.8B
$431.1M
Q2 25
$1.2B
$276.8M
Q1 25
$904.9M
$702.2M
Q4 24
$606.1M
$444.4M
Q3 24
$621.2M
$202.6M
Q2 24
$939.2M
$250.9M
Total Debt
DXCM
DXCM
SBAC
SBAC
Q1 26
$2.7B
Q4 25
$12.9B
Q3 25
$12.7B
Q2 25
$12.5B
Q1 25
$12.4B
Q4 24
$13.6B
Q3 24
$12.3B
Q2 24
$12.3B
Stockholders' Equity
DXCM
DXCM
SBAC
SBAC
Q1 26
$2.7B
Q4 25
$2.7B
$-4.9B
Q3 25
$2.7B
$-4.9B
Q2 25
$2.6B
$-4.9B
Q1 25
$2.3B
$-5.0B
Q4 24
$2.1B
$-5.1B
Q3 24
$2.0B
$-5.2B
Q2 24
$2.4B
$-5.3B
Total Assets
DXCM
DXCM
SBAC
SBAC
Q1 26
$6.3B
$11.7B
Q4 25
$6.3B
$11.6B
Q3 25
$7.5B
$11.3B
Q2 25
$7.3B
$10.8B
Q1 25
$6.8B
$10.4B
Q4 24
$6.5B
$11.4B
Q3 24
$6.4B
$10.2B
Q2 24
$6.8B
$9.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
SBAC
SBAC
Operating Cash FlowLast quarter
$255.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
9.5%
Cash ConversionOCF / Net Profit
1.38×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
SBAC
SBAC
Q1 26
$255.1M
Q4 25
$294.0M
$1.3B
Q3 25
$659.9M
$318.0M
Q2 25
$303.0M
$368.1M
Q1 25
$183.8M
$301.2M
Q4 24
$301.4M
$1.3B
Q3 24
$199.5M
$304.7M
Q2 24
$279.4M
$425.6M
Free Cash Flow
DXCM
DXCM
SBAC
SBAC
Q1 26
Q4 25
$192.1M
$833.3M
Q3 25
$579.4M
$258.0M
Q2 25
$208.9M
$312.2M
Q1 25
$96.8M
$255.0M
Q4 24
$176.8M
$1.2B
Q3 24
$88.3M
$239.9M
Q2 24
$213.3M
$375.6M
FCF Margin
DXCM
DXCM
SBAC
SBAC
Q1 26
Q4 25
15.3%
115.8%
Q3 25
47.9%
35.2%
Q2 25
18.1%
44.7%
Q1 25
9.3%
38.4%
Q4 24
15.9%
179.9%
Q3 24
8.9%
35.9%
Q2 24
21.2%
56.9%
Capex Intensity
DXCM
DXCM
SBAC
SBAC
Q1 26
9.5%
Q4 25
8.1%
63.7%
Q3 25
6.7%
8.2%
Q2 25
8.1%
8.0%
Q1 25
8.4%
7.0%
Q4 24
11.2%
12.6%
Q3 24
11.2%
9.7%
Q2 24
6.6%
7.6%
Cash Conversion
DXCM
DXCM
SBAC
SBAC
Q1 26
1.38×
Q4 25
1.10×
3.49×
Q3 25
2.33×
1.34×
Q2 25
1.69×
1.63×
Q1 25
1.74×
1.36×
Q4 24
1.99×
7.47×
Q3 24
1.48×
1.18×
Q2 24
1.95×
2.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

SBAC
SBAC

Site leasing$656.1M93%
Site development$47.3M7%

Related Comparisons